[REVISION HISTORY]

US corporate earnings reports 2026

Updated 3 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-01 07:54 UTC → 2026-08-01 10:17 UTC · added ~~removed~~

Dexcom’s second‑quarter 2026 results beat expectations, with adjusted EPS of $0.70 versus $0.61 consensus and revenue of $1.31 billion, a 13.1% YoY rise. The company lifted its fiscal‑2026 revenue outlook to $5.18‑$5.25 billion, unveiled the next‑generation G8 CGM, secured FDA clearance for the Stelo over‑the‑counter CGM for children, and completed its Nutrisense acquisition. It ~~also~~ repurchased roughly $600 million of its own stock and saw Avidity Partners add a 1.1% stake. The quarter generated net profit of $249.1 million, or $0.64 per share, and management highlighted strong international sales growth and an expanding margin outlook. Dolby Laboratories reported fiscal Q3 2026 revenue of $305 million, down from the prior year, but posted GAAP net income of $29 million and non‑GAAP EPS of $0.69, beating estimates. The firm repurchased 1.2 million shares for about $65 million and raised full‑year guidance to $4.25‑$4.40 EPS and $1.41‑$1.44 billion revenue, with Q4 EPS projected at $1.13‑$1.28 and revenue $362‑$392 million. Management highlighted a large video‑distribution deal with Meta, expanded licensing with Alibaba, automotive partnerships (Volkswagen, Buick, Android Auto), new RayNeo AR glasses, Dolby Vision 2 TVs from Hisense, TCL and Philips, and the use of Dolby Atmos and Vision for the 2026 FIFA World Cup.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.